human recombinant ATG (GigaGen)

N/A

Report date: 2025/03/20 15:00:10

Base Information

Drug Namehuman recombinant ATG (GigaGen)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Polyclonal antibodies
Mechanisms of ActionImmunomodulatorsT lymphocytes inhibitors
TargetsUpdating
Therapy Area/IndicationsRejection of organ transplantationGraft vs Host Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesGigaGen Inc
China Registration ClassN/A

Develop Information

Active CompaniesGigaGen Inc
Inactive CompaniesN/A
Active IndicationsRejection of organ transplantationGraft vs Host Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A